Lacosamide Medical Valley

Lacosamide, the active ingredient in Lacosamide Medical Valley, is an antiepileptic drug presented as a tablet for oral use. It is used to treat partial‑onset seizures in adults and children aged four years and older.

GNH USA supplies Lacosamide Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an antiepileptic medication indicated for several seizure types.

- Partial‑onset seizures: provides adjunctive control of focal seizures when added to existing therapy. - Primary generalized tonic‑clonic seizures: used as add‑on therapy to reduce seizure frequency. - Epilepsy in pediatric patients: approved for use in children four years of age and older as part of combination treatment.

Lacosamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: mild to moderate stomach upset. - Headache: intermittent pain in the head region. - Fatigue: feeling unusually tired or weak. - Vision changes: blurred or double vision. - Tremor: involuntary shaking of limbs.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm, including PR‑interval prolongation. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Respiratory depression: difficulty breathing, especially when combined with other depressants. - Liver enzyme elevation: significant increase in hepatic transaminases.

When prescribing Lacosamide, clinicians should consider several safety measures.

- Cardiac monitoring: assess ECG for PR‑interval changes before and during therapy. - Renal function: adjust dose in patients with severe renal impairment. - Hepatic function: monitor liver enzymes in patients with existing liver disease. - Concomitant CNS depressants: use caution when combined with other sedating agents. - Pregnancy: evaluate risk‑benefit ratio; limited data available. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Carbamazepine: may reduce lacosamide plasma levels, decreasing efficacy. - Phenytoin: can lower lacosamide concentrations, compromising seizure control. - Strong CYP2C19 inhibitors: may increase lacosamide exposure, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Other sodium‑channel blockers (e.g., lamotrigine): may enhance CNS side effects. - Opioids or benzodiazepines: increased sedation and respiratory depression. - Anticoagulants: potential for altered bleeding risk, monitor INR if applicable.